SILO PHARMA, INC. Interest Receivable, Noncurrent
SILO PHARMA, INC. (SILO) had Interest Receivable, Noncurrent of $9.60 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Receivables › and Others › Nontrade Receivables
us-gaap:InterestReceivableNoncurrent · last filed 2023-11-13
- 2023-09-30: Interest Receivable, Noncurrent $9.60K.
- 2023-06-30: Interest Receivable, Noncurrent $8.39K.
- 2023-03-31: Interest Receivable, Noncurrent $7.19K.
- 2022-12-31: Interest Receivable, Noncurrent $6.01K.
| Period end | Interest Receivable, Noncurrent |
|---|---|
| 2023-09-30 | $9.60K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.39K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $7.19K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $6.01K 10-Q · filed 2023-11-13 |
| 2022-09-30 | $4.80K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.59K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $2.39K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.21K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |